Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

Deficiency of protein C (PC), protein S (PS), antithrombin III (AT III), and homozygosity or combined heterozygosity for Factor V Leiden (FVL) and Factor II (FII) 20210A mutation represent severe hereditary thrombophilia (SHT) and are associated with a higher risk of early-onset venous thromboembol...

Full description

Bibliographic Details
Main Authors: Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso
Format: Article
Language:English
Published: PAGEPress Publications 2021-03-01
Series:Italian Journal of Medicine
Subjects:
Venous thromboembolism
hereditary thrombophilia
direct oral anticoagulants.
Online Access:https://italjmed.org/index.php/ijm/article/view/1351

Internet

https://italjmed.org/index.php/ijm/article/view/1351

Similar Items